Hacer Özlem Kalaycı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hacer Özlem Kalaycı has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Mustafa Kerem Calgin
Department of Medical Microbiology, Faculty of Medicine, Ordu University, Ordu, Türkiye
6 shared publications - Ahmet Burak Gürpınar
Department of Medical Biochemistry, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Türkiye
3 shared publications - Yunus Emre İbIk
Department of Medical Microbiology, Faculty of Medicine, Ordu University, Ordu, Türkiye
3 shared publications - Hüseyin Erdal
Aksaray University
2 shared publications - Soner Yıldız
Department of Medical Microbiology, Faculty of Medicine, Ordu University Training and Research Hospital, Ordu, Türkiye
2 shared publications - Arzu Altunçekiç Yıldırım
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ordu Üniversity, Ordu, Turkey
1 shared publication
Latest Publications
- 1 November 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (11) , 1172-1176
Serological and molecular epidemiology of hepatitis D virus: a four-year single-center retrospective analysis
Aim To assess the serological and molecular epidemiology of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections by analyzing HBV surface antigen (HBsAg), Anti-HDV, and HDV ribonucleic acid (RNA) test results from May 2021 to May 2025 at Ordu University Training and Research Hospital. Methods This single-center retrospective study used Laboratory Information Management System records. Patients aged 0-100 years with at least one request for an HBsAg, Anti-HDV, or HDV RNA test were included. To minimize duplication, only the earliest record per patient for each marker was analyzed. Positivity rates were summarized descriptively and compared by sex and age using Pearson’s chi-square test. Results Among 316,375 individuals tested for HBsAg, 8,054 (2.5%) were positive. HBsAg positivity was higher in men than in women (P = .0011). Positivity was low among those .05). HDV RNA was requested in 64 patients, and 3 (4.68%) were positive. Conclusion HBsAg positivity suggests an intermediate level of HBV endemicity in our region, whereas Anti-HDV seropositivity appears low. Because Anti-HDV and HDV RNA testing were not systematically performed in all HBsAg-positive individuals, the true burden of HDV infection may be underestimated. Standardized screening strategies among HBsAg-positive patients are warranted to better define regional HDV epidemiology.
- 1 November 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (11) , 1172-1176
Serological and molecular epidemiology of hepatitis D virus: a four-year single-center retrospective analysis
Aim To assess the serological and molecular epidemiology of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections by analyzing HBV surface antigen (HBsAg), Anti-HDV, and HDV ribonucleic acid (RNA) test results from May 2021 to May 2025 at Ordu University Training and Research Hospital. Methods This single-center retrospective study used Laboratory Information Management System records. Patients aged 0-100 years with at least one request for an HBsAg, Anti-HDV, or HDV RNA test were included. To minimize duplication, only the earliest record per patient for each marker was analyzed. Positivity rates were summarized descriptively and compared by sex and age using Pearson’s chi-square test. Results Among 316,375 individuals tested for HBsAg, 8,054 (2.5%) were positive. HBsAg positivity was higher in men than in women (P = .0011). Positivity was low among those .05). HDV RNA was requested in 64 patients, and 3 (4.68%) were positive. Conclusion HBsAg positivity suggests an intermediate level of HBV endemicity in our region, whereas Anti-HDV seropositivity appears low. Because Anti-HDV and HDV RNA testing were not systematically performed in all HBsAg-positive individuals, the true burden of HDV infection may be underestimated. Standardized screening strategies among HBsAg-positive patients are warranted to better define regional HDV epidemiology.
- 30 September 2026
- Published by Cumhuriyet University in Cumhuriyet Medical Journal
- Vol. 48 (3) , 102-105
Evaluation of the Association Between ABO and Rh Blood Groups and the Pathogens of Bloodstream Infections
Objective: This study aimed to investigate the relationship between ABO and Rh blood groups and bloodstream infections caused by Gram-positive bacteria, Gram-negative bacteria, and yeasts, and to explore whether blood group polymorphisms contribute to susceptibility to infection.Materials and Methods: A retrospective case–control study was conducted among 2,618 hospitalized patients between May 2021 and May 2024. The case group included 270 patients with positive blood cultures, and the control group comprised 2,348 patients without bloodstream infections. Blood group typing was performed using the DiaMED-ID Micro Typing System® by gel centrifugation method, and microbiological identification was carried out using the BD Phoenix™ M50 automated system. Antimicrobial susceptibility testing followed EUCAST guidelines. Statistical analyses assessed the relationship between blood groups, microorganism types, and clinical variables.Results: The median age of patients with positive blood cultures was significantly higher than that of culture-negative patients (76 vs. 53 years, p < 0.001). The most common blood groups were A Rh-positive (38.7%) and O Rh-positive (30.5%). Among culture-positive patients, blood group A was the most frequent (45.9%), followed by O (30.7%), B (14.1%), and AB (9.3%). The most common pathogens were Staphylococcus aureus (19.3%), Escherichia coli (18.9%), and Enterococcus spp. (18.5%). No statistically significant association was found between ABO/Rh blood groups and bloodstream infection or pathogen distribution. A non-significant trend toward association was observed for Escherichia coli (p = 0.093).Conclusion: ABO and Rh blood groups were not significantly associated with bloodstream infection risk or pathogen distribution. Further studies are needed to clarify potential host-pathogen interactions
- 30 September 2026
- Published by Cumhuriyet University in Cumhuriyet Medical Journal
- Vol. 48 (3) , 102-105
Evaluation of the Association Between ABO and Rh Blood Groups and the Pathogens of Bloodstream Infections
Objective: This study aimed to investigate the relationship between ABO and Rh blood groups and bloodstream infections caused by Gram-positive bacteria, Gram-negative bacteria, and yeasts, and to explore whether blood group polymorphisms contribute to susceptibility to infection.Materials and Methods: A retrospective case–control study was conducted among 2,618 hospitalized patients between May 2021 and May 2024. The case group included 270 patients with positive blood cultures, and the control group comprised 2,348 patients without bloodstream infections. Blood group typing was performed using the DiaMED-ID Micro Typing System® by gel centrifugation method, and microbiological identification was carried out using the BD Phoenix™ M50 automated system. Antimicrobial susceptibility testing followed EUCAST guidelines. Statistical analyses assessed the relationship between blood groups, microorganism types, and clinical variables.Results: The median age of patients with positive blood cultures was significantly higher than that of culture-negative patients (76 vs. 53 years, p < 0.001). The most common blood groups were A Rh-positive (38.7%) and O Rh-positive (30.5%). Among culture-positive patients, blood group A was the most frequent (45.9%), followed by O (30.7%), B (14.1%), and AB (9.3%). The most common pathogens were Staphylococcus aureus (19.3%), Escherichia coli (18.9%), and Enterococcus spp. (18.5%). No statistically significant association was found between ABO/Rh blood groups and bloodstream infection or pathogen distribution. A non-significant trend toward association was observed for Escherichia coli (p = 0.093).Conclusion: ABO and Rh blood groups were not significantly associated with bloodstream infection risk or pathogen distribution. Further studies are needed to clarify potential host-pathogen interactions
- 30 July 2026
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 60 (3) , 318-328
Hepatit C Bakım Kaskadı Analizi: Taramadan Tedaviye Giden Yoldaki Boşlukların Değerlendirilmesi
- 30 July 2026
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 60 (3) , 318-328
Hepatit C Bakım Kaskadı Analizi: Taramadan Tedaviye Giden Yoldaki Boşlukların Değerlendirilmesi
- Open Access
- 29 April 2026
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
- Vol. 10 (1) , 39-47
Frequency of Staphylococcus Aureus Isolates from Clinical Specimens and Changes in Antibiotic Susceptibility Results by Years
Purpose: This study aimed to determine the distribution of S.aureus strains isolated from clinical specimens in a training and research hospital according to clinics and specimen types and evaluate the change in antibiogram results over the years. Materials and Methods: S. aureus strains isolated from various clinical samples in the Microbiology Laboratory of Ordu University Training and Research Hospital between May 2021 and May 2024 were included in the study. Identification and antibiogram results of the isolates were evaluated retrospectively.Results: In our study, 143 (24.2%) of 592 isolates were identified as MRSA and 449 (75.8%) as MSSA. The highest rate of growth was observed in samples from outpatient clinics, and both MRSA and MSSA strains were most frequently isolated from urine samples. The most resistant antimicrobials for MRSA were tetracycline (54.5%), clindamycin (41.3%) and erythromycin (40.6%) while for MSSA erythromycin (21.3%), tetracycline (20.6%) and clindamycin (18.6%). No resistance to daptomycin, linezolid, teicoplanin and vancomycin was found in both strains. Conclusion: Although no glycopeptide resistance was found in S. aureus strains isolated from various cultures in our hospital, TMP/SXT, moxifloxacin, gentamicin and amikacin can be used in the treatment of both MRSA and MSSA. The results of antimicrobial susceptibility tests are important in the selection of appropriate treatment.
- 29 April 2026
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
- Vol. 10 (1) , 39-47
Open AccessFrequency of Staphylococcus Aureus Isolates from Clinical Specimens and Changes in Antibiotic Susceptibility Results by Years
Purpose: This study aimed to determine the distribution of S.aureus strains isolated from clinical specimens in a training and research hospital according to clinics and specimen types and evaluate the change in antibiogram results over the years. Materials and Methods: S. aureus strains isolated from various clinical samples in the Microbiology Laboratory of Ordu University Training and Research Hospital between May 2021 and May 2024 were included in the study. Identification and antibiogram results of the isolates were evaluated retrospectively.Results: In our study, 143 (24.2%) of 592 isolates were identified as MRSA and 449 (75.8%) as MSSA. The highest rate of growth was observed in samples from outpatient clinics, and both MRSA and MSSA strains were most frequently isolated from urine samples. The most resistant antimicrobials for MRSA were tetracycline (54.5%), clindamycin (41.3%) and erythromycin (40.6%) while for MSSA erythromycin (21.3%), tetracycline (20.6%) and clindamycin (18.6%). No resistance to daptomycin, linezolid, teicoplanin and vancomycin was found in both strains. Conclusion: Although no glycopeptide resistance was found in S. aureus strains isolated from various cultures in our hospital, TMP/SXT, moxifloxacin, gentamicin and amikacin can be used in the treatment of both MRSA and MSSA. The results of antimicrobial susceptibility tests are important in the selection of appropriate treatment.
- 1 January 2026
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (4) , 473-480
Relationship of HBV-DNA levels with biochemical and microbiological markers in chronic hepatitis B patients
Objective: HBV-DNA levels are used to diagnose Chronic Hepatitis B (CHB), determine the stage of infection, decide on treatment and determine the course of the disease. HBeAg is a marker of active viral replication and transcription, Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) are markers of liver inflammation. This study aims to investigate the relationship between HBV-DNA levels and age, biochemical and microbiological parameters in patients followed up with a preliminary diagnosis of CHB in our hospital. Materials and Methods: HBV-DNA, microbiological and biochemical parameters test results from blood samples of 264 patients followed up in our hospital with a preliminary diagnosis of CHB between May 2021 and May 2024 were retrospectively analyzed. HBV-DNA levels were divided into three groups as HBV-DNA Negative (Group 1), HBV-DNA 10-2000 IU/mL (Group 2) and HBV-DNA>2000 IU/mL (Group 3). Statistical analyses were performed with the MedCalc (version 20.009; Ostend, Belgium) statistical package program. Results: HBeAg positivity was significantly lower in HBV-DNA negative patients compared to patients with HBV-DNA 10-2000 IU/mL and HBV-DNA >2000 IU/mL and in patients with HBV-DNA 10-2000 IU/mL compared to patients with HBV-DNA >2000 IU/mL (p2000 IU/mL compared to patients with HBV-DNA negative and HBV-DNA 10-2000 IU/mL. No statistically significant correlation was found between HBV-DNA levels and WBC, HGB, MCV, RDW, GGT, ALP, Total protein, albumin, PT, aPTT, INR values. Conclusion: A significant relationship was found between HBeAg and ALT, AST values and HBV-DNA levels in CHB patients. These parameters can be used together to diagnose CHB disease, establish the stage of infection, decide on treatment and determine the course of the disease.
- 1 January 2026
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (4) , 473-480
Relationship of HBV-DNA levels with biochemical and microbiological markers in chronic hepatitis B patients
Objective: HBV-DNA levels are used to diagnose Chronic Hepatitis B (CHB), determine the stage of infection, decide on treatment and determine the course of the disease. HBeAg is a marker of active viral replication and transcription, Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) are markers of liver inflammation. This study aims to investigate the relationship between HBV-DNA levels and age, biochemical and microbiological parameters in patients followed up with a preliminary diagnosis of CHB in our hospital. Materials and Methods: HBV-DNA, microbiological and biochemical parameters test results from blood samples of 264 patients followed up in our hospital with a preliminary diagnosis of CHB between May 2021 and May 2024 were retrospectively analyzed. HBV-DNA levels were divided into three groups as HBV-DNA Negative (Group 1), HBV-DNA 10-2000 IU/mL (Group 2) and HBV-DNA>2000 IU/mL (Group 3). Statistical analyses were performed with the MedCalc (version 20.009; Ostend, Belgium) statistical package program. Results: HBeAg positivity was significantly lower in HBV-DNA negative patients compared to patients with HBV-DNA 10-2000 IU/mL and HBV-DNA >2000 IU/mL and in patients with HBV-DNA 10-2000 IU/mL compared to patients with HBV-DNA >2000 IU/mL (p2000 IU/mL compared to patients with HBV-DNA negative and HBV-DNA 10-2000 IU/mL. No statistically significant correlation was found between HBV-DNA levels and WBC, HGB, MCV, RDW, GGT, ALP, Total protein, albumin, PT, aPTT, INR values. Conclusion: A significant relationship was found between HBeAg and ALT, AST values and HBV-DNA levels in CHB patients. These parameters can be used together to diagnose CHB disease, establish the stage of infection, decide on treatment and determine the course of the disease.
- 31 December 2025
- Published by Ordu University in ODÜ Tıp Dergisi
- Vol. 12 (3) , 114-122
HPV Tanısı Konmuş Hastaların Genitoüriner Sisteminde Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis ve Ureaplasma urealyticum Sıklığının Araştırılması
Amaç: Bu çalışmada cinsel yolla bulaşan Neisseria gonorrhoeae, Chlamidya trachomatis, Mycoplasma hominis ve Ureaplasma urealyticum patojenlerinin klinik olarak HPV tanısı konmuş hastalardaki sıklığının araştırılması ve yanlış tedavi seçeneklerinin ortadan kaldırılması amaçlanmıştır. Yöntem: Çalışma kapsamına OMÜ Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilimdalı polikliniğine başvuran vajinal akıntısı olan 92 kadın dahil edilmiştir. 92 kadının 46’sı klinik olarak HPV(+) tanısı almış hasta grubunu, 46’sı klinik olarak HPV(-) kontrol grubunu oluşturmuştur. C.trachomatis ve N.gonorrhoeae Real-time PCR yöntemi ile, M.hominis ve U.urealyticum Mycoplasma IST 2 kit yöntemi ile araştırılmıştır. Bulgular: Mycoplasma IST 2 kiti ile çalışılan örneklerden kontrol ve hasta grubundaki toplam 92 kadından 80’inde (≥104 CFU/ml) üreme saptanmıştır. Ayrıca hasta grubunda 5 kişide hem M.hominis (≥104 CFU/ml) hem de U.urealyticum (≥104 CFU/ml) tespit edilmiştir. Hasta grubundan 43 kişide, kontrol grubundan 37 kişide U.urealyticum izole edilmiştir. Yapılan Fisher ve düzeltilmiş Yates istatistiksel analizde hasta ve kontrol grupları arasında HPV(+)’liğiyle anlamlı bir fark bulunmamıştır (p>0,05). Hasta grubundan izole edilen mikroorganizmaların antibiyotik duyarlılıkları değerlendirildiğinde; en yüksek derecede direnç eritromisin, tetrasiklin, klaritromisine karşı görülmüştür. Tüm M.hominis suşları eritromisin ve tetrasikline dirençli bulunmuştur. Bir hastada test edilen bütün antibiyotiklere direnç saptanmıştır ve bu hastada M.hominis ve U.urealyticum birlikte izole edilmiştir. Kontrol grubunda üreyen 37 U.urealyticum da ise en yüksek derecede direnç ofloksasin ve eritromisine karşı görülmüştür. Duplica Real Time Advanced C.trachomatis ve Duplica Real Time Advanced N.gonorrhoeae kitleri ile çalışılan örneklerden 2 kişide C.trachomatis PCR sonucu pozitif bulunmuştur. Hiçbir hastada N.gonorrhoeae DNA tespit edilememiştir. Pozitif bulunan 2 C.trachomatis DNA sonucu HPV (+) olan hasta grubuna dahil ve bu 2 hastada Mycoplasma IST 2 kiti ile yapılan çalışmada M.hominis ve U.urealyticum pozitifliği de tespit edilmiştir. Sonuç: Sonuç olarak bizim çalışmamızda da diğer çalışmalarla benzer olarak U.urealyticum’a M.hominis’ten daha sık rastlanmıştır. İstatistiksel analizde klinik olarak HPV (+)’liğinin C.trachomatis, U.urealyticum ve M.hominis birlikteliğiyle anlamlı bir ilişkisinin olduğu saptanmamıştır (p>0,05). C.trachomatis, N.gonorrhoeae, M.hominis ve U.urealyticum’un hakkında çalışmalar arttıkça daha doğru sonuçlar elde edilebilecektir.
- 31 December 2025
- Published by Ordu University in ODÜ Tıp Dergisi
- Vol. 12 (3) , 114-122
HPV Tanısı Konmuş Hastaların Genitoüriner Sisteminde Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis ve Ureaplasma urealyticum Sıklığının Araştırılması
Amaç: Bu çalışmada cinsel yolla bulaşan Neisseria gonorrhoeae, Chlamidya trachomatis, Mycoplasma hominis ve Ureaplasma urealyticum patojenlerinin klinik olarak HPV tanısı konmuş hastalardaki sıklığının araştırılması ve yanlış tedavi seçeneklerinin ortadan kaldırılması amaçlanmıştır. Yöntem: Çalışma kapsamına OMÜ Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilimdalı polikliniğine başvuran vajinal akıntısı olan 92 kadın dahil edilmiştir. 92 kadının 46’sı klinik olarak HPV(+) tanısı almış hasta grubunu, 46’sı klinik olarak HPV(-) kontrol grubunu oluşturmuştur. C.trachomatis ve N.gonorrhoeae Real-time PCR yöntemi ile, M.hominis ve U.urealyticum Mycoplasma IST 2 kit yöntemi ile araştırılmıştır. Bulgular: Mycoplasma IST 2 kiti ile çalışılan örneklerden kontrol ve hasta grubundaki toplam 92 kadından 80’inde (≥104 CFU/ml) üreme saptanmıştır. Ayrıca hasta grubunda 5 kişide hem M.hominis (≥104 CFU/ml) hem de U.urealyticum (≥104 CFU/ml) tespit edilmiştir. Hasta grubundan 43 kişide, kontrol grubundan 37 kişide U.urealyticum izole edilmiştir. Yapılan Fisher ve düzeltilmiş Yates istatistiksel analizde hasta ve kontrol grupları arasında HPV(+)’liğiyle anlamlı bir fark bulunmamıştır (p>0,05). Hasta grubundan izole edilen mikroorganizmaların antibiyotik duyarlılıkları değerlendirildiğinde; en yüksek derecede direnç eritromisin, tetrasiklin, klaritromisine karşı görülmüştür. Tüm M.hominis suşları eritromisin ve tetrasikline dirençli bulunmuştur. Bir hastada test edilen bütün antibiyotiklere direnç saptanmıştır ve bu hastada M.hominis ve U.urealyticum birlikte izole edilmiştir. Kontrol grubunda üreyen 37 U.urealyticum da ise en yüksek derecede direnç ofloksasin ve eritromisine karşı görülmüştür. Duplica Real Time Advanced C.trachomatis ve Duplica Real Time Advanced N.gonorrhoeae kitleri ile çalışılan örneklerden 2 kişide C.trachomatis PCR sonucu pozitif bulunmuştur. Hiçbir hastada N.gonorrhoeae DNA tespit edilememiştir. Pozitif bulunan 2 C.trachomatis DNA sonucu HPV (+) olan hasta grubuna dahil ve bu 2 hastada Mycoplasma IST 2 kiti ile yapılan çalışmada M.hominis ve U.urealyticum pozitifliği de tespit edilmiştir. Sonuç: Sonuç olarak bizim çalışmamızda da diğer çalışmalarla benzer olarak U.urealyticum’a M.hominis’ten daha sık rastlanmıştır. İstatistiksel analizde klinik olarak HPV (+)’liğinin C.trachomatis, U.urealyticum ve M.hominis birlikteliğiyle anlamlı bir ilişkisinin olduğu saptanmamıştır (p>0,05). C.trachomatis, N.gonorrhoeae, M.hominis ve U.urealyticum’un hakkında çalışmalar arttıkça daha doğru sonuçlar elde edilebilecektir.
- Open Access
- 25 March 2025
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (1) , 1-6
Distribution of hepatitis C virus genotypes in Ordu province
Aim: Hepatitis C virus (HCV) infection is a major health problem worldwide and leads to chronic liver disease, cirrhosis, and hepatocellular carcinoma. Genotype 1, the most common genotype worldwide, usually requires longer and more complex treatment regimens compared to other genotypes. HCV infection is closely associated with changes in liver enzyme levels, especially alanine aminotransferase (ALT). This study aims to determine the distribution of HCV genotypes in chronic HCV patients and to investigate the relationship between HCV genotype and serum ALT levels. Material and Methods: In this retrospective study, the outcomes of patients diagnosed with chronic liver disease due to HCV at Ordu University Medical Faculty, Education and Research Hospital between May 2021 and October 2023 were analyzed. HCV genotyping was performed using the Bosphore HCV Genotyping Kit v5 (Anatolia Geneworks, Türkiye) according to the manufacturer's instructions. Serum ALT levels were measured using the electrochemiluminescence immunoassay method (Cobas e 601, Roche, Germany). Results: A total of 219 HCV-RNA positive patients were included in the study. Of all patients, 125 (57.1%) were female and 94 (42.9%) were male. When genotype distribution was examined, it was seen that 200 patients (91.3%) had genotype 1b, 9 patients (4.1%) had genotype 1a, 7 patients (3.2%) had genotype 3, 2 patients (0.9%) had genotype 1, and 1 patient (0.5%) had genotype 4. A total of 9 patients had serum ALT levels above 40 IU/L. Conclusion: Genotype 1b remains the most frequently detected genotype among our patients, while the prevalence of Genotype 3 has changed over the years. No significant differences were found in serum ALT levels, mean age, and gender distribution between patients infected with Genotype 1 and other genotypes.
- 25 March 2025
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 16 (1) , 1-6
Open AccessDistribution of hepatitis C virus genotypes in Ordu province
Aim: Hepatitis C virus (HCV) infection is a major health problem worldwide and leads to chronic liver disease, cirrhosis, and hepatocellular carcinoma. Genotype 1, the most common genotype worldwide, usually requires longer and more complex treatment regimens compared to other genotypes. HCV infection is closely associated with changes in liver enzyme levels, especially alanine aminotransferase (ALT). This study aims to determine the distribution of HCV genotypes in chronic HCV patients and to investigate the relationship between HCV genotype and serum ALT levels. Material and Methods: In this retrospective study, the outcomes of patients diagnosed with chronic liver disease due to HCV at Ordu University Medical Faculty, Education and Research Hospital between May 2021 and October 2023 were analyzed. HCV genotyping was performed using the Bosphore HCV Genotyping Kit v5 (Anatolia Geneworks, Türkiye) according to the manufacturer's instructions. Serum ALT levels were measured using the electrochemiluminescence immunoassay method (Cobas e 601, Roche, Germany). Results: A total of 219 HCV-RNA positive patients were included in the study. Of all patients, 125 (57.1%) were female and 94 (42.9%) were male. When genotype distribution was examined, it was seen that 200 patients (91.3%) had genotype 1b, 9 patients (4.1%) had genotype 1a, 7 patients (3.2%) had genotype 3, 2 patients (0.9%) had genotype 1, and 1 patient (0.5%) had genotype 4. A total of 9 patients had serum ALT levels above 40 IU/L. Conclusion: Genotype 1b remains the most frequently detected genotype among our patients, while the prevalence of Genotype 3 has changed over the years. No significant differences were found in serum ALT levels, mean age, and gender distribution between patients infected with Genotype 1 and other genotypes.
- Open Access
- 12 January 2025
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 8 (1) , 80-84
Evaluation of the In vitro efficacy of ceftazidime-avibactam against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolates from respiratory tract cultures in intensive care units
Aims: Worldwide, an increase in multidrug resistance is observed in Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), and Pseudomonas aeruginosa (P. aeruginosa) isolates, leading to challenges in the treatment of infections caused by these pathogens. This study aims to investigate the in vitro efficacy of ceftazidime-avibactam (CZA) against isolates containing K. pneumoniae, E. coli, and P. aeruginosa strains obtained from respiratory tract samples sent from intensive care units. Methods: A retrospective analysis was conducted on 653 Enterobacterales (E. coli, K. pneumoniae) and P. aeruginosa isolates obtained from respiratory tract cultures, including sputum, tracheal aspirates, and bronchial lavage, from patients over 18 years old admitted to the intensive care units of Ordu University Training and Research Hospital between May 1, 2021, and May 1, 2024. Automated systems were used to identify the pathogens and perform antibiotic susceptibility testing. Discriptive data analysis was conducted using SPSS version 24.0. Results: A total of 653 isolates from respiratory tract samples were included in the study, consisting of 368 Enterobacteriaceae [61 E. coli (9.3%) and 307 K. pneumoniae (47%)] and 285 P. aeruginosa (43.7%). These samples were isolated from endotracheal aspirate (69.5%), sputum (27.9%), and bronchoalveolar lavage (2.6%). Among all isolates, 364 (55.7%) were found to be sensitive to carbapenems, while 289 (44.3%) were carbapenem-resistant. Of the samples, 631 (96.6%) were sensitive to CZA, while 22 (3.4%) were resistant. Although resistance to CZA was detected in 3.6% of K. pneumoniae isolates and 3.9% of P. aeruginosa isolates, no resistance was detected in E. coli. Colistin resistance was observed in 15.3% of K. pneumoniae and 5.6% of P. aeruginosa isolates, but was absent in E. coli isolates. Resistance rates to other antibiotics were as follows for E. coli, K. pneumoniae, and P. aeruginosa isolates, respectively: amikacin (3.3%, 46.6%, 8.1%), ciprofloxacin (73.8%, 73.6%, 85.9%), ceftazidime (67.2%, 77.8%, 35.8%), piperacillin-tazobactam (26.2%, 70%, 37.2%), and trimethoprim-sulfamethoxazole (52.5%, 66.4%, 0%). Conclusion: In our study, CZA was found to be the most effective antibiotic against multidrug-resistant Enterobacterales and P. aeruginosa isolates, followed by colistin.
- 12 January 2025
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 8 (1) , 80-84
Open AccessEvaluation of the In vitro efficacy of ceftazidime-avibactam against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolates from respiratory tract cultures in intensive care units
Aims: Worldwide, an increase in multidrug resistance is observed in Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), and Pseudomonas aeruginosa (P. aeruginosa) isolates, leading to challenges in the treatment of infections caused by these pathogens. This study aims to investigate the in vitro efficacy of ceftazidime-avibactam (CZA) against isolates containing K. pneumoniae, E. coli, and P. aeruginosa strains obtained from respiratory tract samples sent from intensive care units. Methods: A retrospective analysis was conducted on 653 Enterobacterales (E. coli, K. pneumoniae) and P. aeruginosa isolates obtained from respiratory tract cultures, including sputum, tracheal aspirates, and bronchial lavage, from patients over 18 years old admitted to the intensive care units of Ordu University Training and Research Hospital between May 1, 2021, and May 1, 2024. Automated systems were used to identify the pathogens and perform antibiotic susceptibility testing. Discriptive data analysis was conducted using SPSS version 24.0. Results: A total of 653 isolates from respiratory tract samples were included in the study, consisting of 368 Enterobacteriaceae [61 E. coli (9.3%) and 307 K. pneumoniae (47%)] and 285 P. aeruginosa (43.7%). These samples were isolated from endotracheal aspirate (69.5%), sputum (27.9%), and bronchoalveolar lavage (2.6%). Among all isolates, 364 (55.7%) were found to be sensitive to carbapenems, while 289 (44.3%) were carbapenem-resistant. Of the samples, 631 (96.6%) were sensitive to CZA, while 22 (3.4%) were resistant. Although resistance to CZA was detected in 3.6% of K. pneumoniae isolates and 3.9% of P. aeruginosa isolates, no resistance was detected in E. coli. Colistin resistance was observed in 15.3% of K. pneumoniae and 5.6% of P. aeruginosa isolates, but was absent in E. coli isolates. Resistance rates to other antibiotics were as follows for E. coli, K. pneumoniae, and P. aeruginosa isolates, respectively: amikacin (3.3%, 46.6%, 8.1%), ciprofloxacin (73.8%, 73.6%, 85.9%), ceftazidime (67.2%, 77.8%, 35.8%), piperacillin-tazobactam (26.2%, 70%, 37.2%), and trimethoprim-sulfamethoxazole (52.5%, 66.4%, 0%). Conclusion: In our study, CZA was found to be the most effective antibiotic against multidrug-resistant Enterobacterales and P. aeruginosa isolates, followed by colistin.
- 3 January 2025
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 15 (1) , 15-19
Bir Eğitim ve Araştırma Hastanesindeki Sağlık Çalışanlarında Hepatit A, Hepatit B, Hepatit C ve İnsan Bağışıklık Yetmezliği Virüsü Seroprevalansının Araştırılması
Amaç: Sağlık çalışanları sıklıkla enfeksiyon hastalıklarına özellikle de kan ve kan ürünleriyle bulaşan patojenlere karşı risk altındadır. Çalışmamızda Ordu Üniversitesi Eğitim ve Araştırma Hastanesi’ndeki 01.05.2022 - 30.04.2023 tarihleri arasında rutin sağlık taraması yapılan sağlık çalışanlarında mesleki risk oluşturan hepatit A, hepatit B, hepatit C ve insan bağışıklık yetmezliği virüsü (HIV) seroprevalansının belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Hastanemiz çalışanlarına sağlık taraması yapılmıştır. Yapılan tarama sonuçları retrospektif olarak analiz edilmiştir. Sağlık taraması için alınan serum örneklerinden HBsAg, anti-HBs, anti-HCV, anti-HAV IgG ve anti-HIV testleri laboratuvarımızda kemiluminesans immunassay yöntemi (Roche Diagnostics, Mannheim, Almanya) ile çalışılmıştır. Bulgular: Çalışmaya toplam 771 sağlık çalışanı dahil edilmiştir. Sağlık çalışanlarında HBsAg pozitifliği %1,16, Anti-HBs pozitifliği %88, Anti-HCV pozitifliği %0,2 ve Anti-HAV IgG pozitifliği ise %55,5 olarak tespit edilmiştir. Anti-HCV pozitif saptadığımız 2 çalışanımıza HCV-RNA testi çalışılmış ve test sonucu negatif bulunmuştur. Hiçbir sağlık çalışanımızda Anti-HIV pozitifliğine rastlanmamıştır. 45 yaşından büyük sağlık çalışanlarında Anti-HAV IgG pozitifliği %96,7 ve Anti-HBs pozitifliği %94,3 bulunmuştur. Sonuç: Sağlık çalışanlarının tarama muayenelerinin düzenli olarak yapılarak, bulaş riskinin olduğu hastalıklara karşı eğitimler verilmeli, aşı ile önlenebilir hastalıklar yönünden aşılanmaları teşvik edilmelidir.
- 3 January 2025
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 15 (1) , 15-19
Bir Eğitim ve Araştırma Hastanesindeki Sağlık Çalışanlarında Hepatit A, Hepatit B, Hepatit C ve İnsan Bağışıklık Yetmezliği Virüsü Seroprevalansının Araştırılması
Amaç: Sağlık çalışanları sıklıkla enfeksiyon hastalıklarına özellikle de kan ve kan ürünleriyle bulaşan patojenlere karşı risk altındadır. Çalışmamızda Ordu Üniversitesi Eğitim ve Araştırma Hastanesi’ndeki 01.05.2022 - 30.04.2023 tarihleri arasında rutin sağlık taraması yapılan sağlık çalışanlarında mesleki risk oluşturan hepatit A, hepatit B, hepatit C ve insan bağışıklık yetmezliği virüsü (HIV) seroprevalansının belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Hastanemiz çalışanlarına sağlık taraması yapılmıştır. Yapılan tarama sonuçları retrospektif olarak analiz edilmiştir. Sağlık taraması için alınan serum örneklerinden HBsAg, anti-HBs, anti-HCV, anti-HAV IgG ve anti-HIV testleri laboratuvarımızda kemiluminesans immunassay yöntemi (Roche Diagnostics, Mannheim, Almanya) ile çalışılmıştır. Bulgular: Çalışmaya toplam 771 sağlık çalışanı dahil edilmiştir. Sağlık çalışanlarında HBsAg pozitifliği %1,16, Anti-HBs pozitifliği %88, Anti-HCV pozitifliği %0,2 ve Anti-HAV IgG pozitifliği ise %55,5 olarak tespit edilmiştir. Anti-HCV pozitif saptadığımız 2 çalışanımıza HCV-RNA testi çalışılmış ve test sonucu negatif bulunmuştur. Hiçbir sağlık çalışanımızda Anti-HIV pozitifliğine rastlanmamıştır. 45 yaşından büyük sağlık çalışanlarında Anti-HAV IgG pozitifliği %96,7 ve Anti-HBs pozitifliği %94,3 bulunmuştur. Sonuç: Sağlık çalışanlarının tarama muayenelerinin düzenli olarak yapılarak, bulaş riskinin olduğu hastalıklara karşı eğitimler verilmeli, aşı ile önlenebilir hastalıklar yönünden aşılanmaları teşvik edilmelidir.
- 1 December 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (12) , 871-875
Comparison of urine culture and complete urinalysis results in female patients with suspected urinary tract infection
Aim This study aims to assess the effectiveness of fully automated urine tests by using urine culture results from female patients with suspected urinary tract infections as the reference standard and to determine their practicality for clinicians. Methods Chemical and microscopic analysis of urine was performed using a fully automatic urine analyzer (Roche Cobas 6500 u601-u701, Roche Diagnostics GmbH, Mannheim, Germany) in patients with a preliminary diagnosis of symptomatic urinary tract infection who were admitted to xxx University Training and Research Hospital gynecology outpatient clinic between January 2023 and January 2024. Midstream urine samples sent in sterile containers were inoculated on 5% sheep blood agar and EMB agar with a 0.001 caliber core and incubated at 37°C for 18-24 hours under aerop conditions. According to complete urinalysis, leukocyte count ≥5 and bacterial count ≥1 were considered positive, leukocyte esterase positivity and nitrite positivity were considered positive. Results Escherichia coli (E.coli), Streptococcus agalactiae, Klebsiella pneumoniae, Staphylococcus sapropyticus and Candida spp. were most frequently isolated from a total of 295 urine cultures. The most effective antibiotics against the isolated E.coli strains were nitrofurantoin, fosfomycin, imipenem, meropenem and amikacin. When culture results were taken as gold standard, the diagnostic sensitivity, specificity and accuracy rates of leukocyte esterase and nitrite positivity were 78.3%, 44%, 52.1%, 24.1%, 99.9%, 82.1% for leukocyte esterase and nitrite, respectively. Conclusion We think that nitrite positivity may be a guide for unnecessary urine culture requests, but urinalysis parameters should not be used instead of culture due to their low accuracy rates.
- 1 December 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (12) , 871-875
Comparison of urine culture and complete urinalysis results in female patients with suspected urinary tract infection
Aim This study aims to assess the effectiveness of fully automated urine tests by using urine culture results from female patients with suspected urinary tract infections as the reference standard and to determine their practicality for clinicians. Methods Chemical and microscopic analysis of urine was performed using a fully automatic urine analyzer (Roche Cobas 6500 u601-u701, Roche Diagnostics GmbH, Mannheim, Germany) in patients with a preliminary diagnosis of symptomatic urinary tract infection who were admitted to xxx University Training and Research Hospital gynecology outpatient clinic between January 2023 and January 2024. Midstream urine samples sent in sterile containers were inoculated on 5% sheep blood agar and EMB agar with a 0.001 caliber core and incubated at 37°C for 18-24 hours under aerop conditions. According to complete urinalysis, leukocyte count ≥5 and bacterial count ≥1 were considered positive, leukocyte esterase positivity and nitrite positivity were considered positive. Results Escherichia coli (E.coli), Streptococcus agalactiae, Klebsiella pneumoniae, Staphylococcus sapropyticus and Candida spp. were most frequently isolated from a total of 295 urine cultures. The most effective antibiotics against the isolated E.coli strains were nitrofurantoin, fosfomycin, imipenem, meropenem and amikacin. When culture results were taken as gold standard, the diagnostic sensitivity, specificity and accuracy rates of leukocyte esterase and nitrite positivity were 78.3%, 44%, 52.1%, 24.1%, 99.9%, 82.1% for leukocyte esterase and nitrite, respectively. Conclusion We think that nitrite positivity may be a guide for unnecessary urine culture requests, but urinalysis parameters should not be used instead of culture due to their low accuracy rates.